During the past decade, The Ohio State University Dermatology East conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Ohio State University Dermatology East" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Ohio State University Dermatology East" are "Dermatitis, Atopic" (2 trials), "Cellulitis" (1 trials), "Pseudocellulitis" (1 trials) and "Pyoderma Gangrenosum" (1 trials). Many other conditions were trialed in "The Ohio State University Dermatology East" in a lesser frequency.

Most popular intervention types in "The Ohio State University Dermatology East" are "Drug" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Ixekizumab" (1 trials) and "PF-04965842 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Ohio State University Dermatology East" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The Ohio State University Dermatology East". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Ohio State University Dermatology East, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Ohio State University Dermatology East, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".